Industry Groups Praise Intravascular DRG Assignment, Question CMS Methods
This article was originally published in The Gray Sheet
Executive Summary
The Medical Device Manufacturers Association is commending CMS' assignment of intravascular brachytherapy devices to the same diagnosis-related group as coronary stents, but is skeptical of the agency's vague reasoning behind the decision.